LENZ Therapeutics
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $3,384 | $5,486 | $1,901 | $1,588 |
Gross Profit | 2,930 | 5,206 | 714 | 1,063 |
EBITDA | -32,918 | -31,805 | -41,377 | -35,787 |
EBIT | -31,915 | -41,488 | -35,894 | |
Net Income | -30,969 | -31,918 | -41,488 | -35,896 |
Net Change In Cash | 3,384 | 5,486 | 1,901 | 1,588 |
Free Cash Flow | -38,729 | -33,600 | -33,063 | |
Cash | 24,208 | 24,772 | 25,179 | |
Basic Shares | 31,420 | 31,374 | 31,352 | 31,071 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $19,088 | $0 | $0 | $15,000 |
Gross Profit | 18,383 | -58 | -2,407 | 15,000 |
EBITDA | -81,338 | -49,710 | -70,132 | -10,456 |
EBIT | -81,625 | -49,768 | -70,147 | -10,464 |
Net Income | -82,127 | -49,769 | -69,968 | -10,811 |
Net Change In Cash | 19,088 | 0 | 0 | 15,000 |
Free Cash Flow | -69,997 | -59,859 | -60,410 | -94,574 |
Cash | 25,179 | 20,158 | 35,140 | 44,441 |
Basic Shares | 28,813 | 21,281 | 8,145 | 7,839 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.99 |
2026-06-30 | -$1.02 |
2026-03-31 | -$1.32 |
2025-12-31 | -$1.16 |